Home › Mecwins Technology
A revolutionary digital technology able to count single protein molecules — opening a window on the world of proteins.
the science
The human genome represents a world of coded proteins, a world where tiny changes can make the difference between sickness and health. Observing these changes can help direct diagnosis and treatment in areas like oncology, cardiovascular disease, neurology, and more.
The vast majority of proteins are poorly understood or only present in concentrations below what conventional technologies can measure. Until now, a window has been opened on the world of proteins by Mecwins’ revolutionary AVAC technology.

single molecule counting
Mecwins technology is a revolutionary digital technology able to count single protein molecules, to achieve ultra-high sensitivity — several orders of magnitude better than conventional immunoassays — remarkable throughput, multiplexing and a broad dynamic range.
our platforms
The AVAC technology is available through two complementary instruments designed for research and clinical environments.
Ultra-high sensitivity analyzer, several orders of magnitude better than conventional immunoassays, with remarkable throughput, multiplexing, best-in-class CVs and a broad dynamic range.
Instrumentation platform built on Mecwins’ single-particle digital counting, enabling ultrasensitive detection of protein biomarkers for research applications.
frequently asked
Mecwins’ technology is a digital technology able to count single protein molecules, achieving ultra-high sensitivity — several orders of magnitude better than conventional immunoassays — together with remarkable throughput, multiplexing and a broad dynamic range.
It delivers ultra-high sensitivity, several orders of magnitude better than conventional immunoassays. The AVAC Analyzer detects biomarkers in the femtogram range.
They are two complementary instruments built on the same AVAC technology. The AVAC Analyzer is an ultra-high-sensitivity analyzer with remarkable throughput, multiplexing, best-in-class CVs and a broad dynamic range. SCALA is an instrumentation platform built on Mecwins’ single-particle digital counting for ultrasensitive detection of protein biomarkers in research.
Ultrasensitive biomarker detection across oncology, cardiology, neurology, immunology and infectious disease.
Yes. Mecwins offers immunoassay development and nanoparticle functionalization and characterization services.